ArticleJournal of medicinal chemistry2026

Discovery of Highly Efficacious CRBN-Based KRAS Degraders Targeting Cancers with KRAS G12D and G12V Mutations.

Changwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.